Carlos N. Martinez

Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts

Michael F. Sharpnack, D. Schadendorf, R. Sullivan, 2018, Journal of Translational Medicine.

Tumor immunogenomic signatures improve a prognostic model of melanoma survival

T. Kirchhoff, I. Osman, J. Weber, 2021, Journal of Translational Medicine.

The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma Prognosis

T. Kirchhoff, I. Osman, R. Berman, 2016, Clinical Cancer Research.

Functional analysis of RPS27 mutations and expression in melanoma

T. Kirchhoff, I. Dolgalev, I. Osman, 2020, Pigment cell & melanoma research.

Genetic markers of pigmentation are novel risk loci for uveal melanoma

R. Klein, I. Osman, M. Abdel-Rahman, 2016, Scientific Reports.

Mutation burden as a potential prognostic marker of melanoma progression and survival.

Adriana Heguy, A. Heguy, T. Kirchhoff, 2017 .

Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma

T. Kirchhoff, D. Polsky, I. Osman, 2015, Journal of Medical Genetics.

Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts

Michael F. Sharpnack, D. Schadendorf, R. Sullivan, 2018, Journal of Translational Medicine.